학술논문
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression
Document Type
Article
Author
Source
In: British Journal of Haematology . (British Journal of Haematology, 1 June 2020, 189(6):1064-1073)
Subject
Language
English
ISSN
13652141
00071048
00071048